In their study published in Nature Communications, researchers identified an unusual type of brain cell they named “ovoid ...
As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...
Foods, drinks and supplements with mushrooms are being added to the market constantly. Lion's mane mushrooms, specifically, ...
Researchers at Washington University School of Medicine in St. Louis have conducted a longitudinal study on an individual ...
Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...
While watches are inherently genderless objects, they have nevertheless historically been marketed to either men or women in ...
Whether you're shopping for a holistic health connoisseur or a fitness enthusiast, our editors' favorite picks have you ...
2d
Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered NimodipineNew Drug Application ...
When Lillian Ross profiled the celebrated novelist, the world saw ridicule and ruin. But letters between the reporter and her ...
After wildfires displaced thousands of Angelenos, a patchwork of cooks, restaurateurs, and volunteers have operated something ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
LOS ANGELES -- In the PRESTIGE-AF trial, survivors of intracerebral hemorrhage (ICH) had good protection against future ischemic events using direct oral anticoagulants (DOACs) -- though, as feared, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback